Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 22179132)

1.

Risk prediction models: a framework for assessment.

Dent TH, Wright CF, Stephan BC, Brayne C, Janssens AC.

Public Health Genomics. 2012;15(2):98-105. doi: 10.1159/000334436. Epub 2011 Dec 14.

PMID:
22179132
2.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

3.
4.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
5.

Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.

Korczak D, Dietl M, Steinhauser G.

GMS Health Technol Assess. 2011 Apr 1;7:Doc02. doi: 10.3205/hta000093.

6.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
7.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. German.

PMID:
19034813
8.

Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.

Flynn MA, McNeil DA, Maloff B, Mutasingwa D, Wu M, Ford C, Tough SC.

Obes Rev. 2006 Feb;7 Suppl 1:7-66. Review.

PMID:
16371076
9.
10.

Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients.

Fung CS, Chin WY, Dai DS, Kwok RL, Tsui EL, Wan YF, Wong W, Wong CK, Fong DY, Lam CL.

BMC Fam Pract. 2012 Dec 5;13:116. doi: 10.1186/1471-2296-13-116.

11.

Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.

Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G, Linton B.

J Toxicol Environ Health A. 2002 Jan 11;65(1):1-142. Review.

PMID:
11809004
13.
14.

One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease.

Alssema M, Newson RS, Bakker SJ, Stehouwer CD, Heymans MW, Nijpels G, Hillege HL, Hofman A, Witteman JC, Gansevoort RT, Dekker JM.

Diabetes Care. 2012 Apr;35(4):741-8. doi: 10.2337/dc11-1417. Epub 2012 Feb 14.

15.

Cancer risk prediction models: a workshop on development, evaluation, and application.

Freedman AN, Seminara D, Gail MH, Hartge P, Colditz GA, Ballard-Barbash R, Pfeiffer RM.

J Natl Cancer Inst. 2005 May 18;97(10):715-23.

16.

How to anticipate the assessment of the public health benefit of new medicines?

Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII.

Therapie. 2007 Sep-Oct;62(5):427-35. doi: 10.2515/therapie:2007071. Epub 2008 Jan 19.

PMID:
18206104
17.

Family pediatrics: report of the Task Force on the Family.

Schor EL; American Academy of Pediatrics Task Force on the Family.

Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.

PMID:
12777595
18.

Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.

Kengne AP, Patel A, Marre M, Travert F, Lievre M, Zoungas S, Chalmers J, Colagiuri S, Grobbee DE, Hamet P, Heller S, Neal B, Woodward M; ADVANCE Collaborative Group.

Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):393-8. doi: 10.1177/1741826710394270. Epub 2011 Feb 28.

PMID:
21450612
19.

Disease transmission models for public health decision making: analysis of epidemic and endemic conditions caused by waterborne pathogens.

Eisenberg JN, Brookhart MA, Rice G, Brown M, Colford JM Jr.

Environ Health Perspect. 2002 Aug;110(8):783-90.

20.

Risk prediction models: II. External validation, model updating, and impact assessment.

Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M.

Heart. 2012 May;98(9):691-8. doi: 10.1136/heartjnl-2011-301247. Epub 2012 Mar 7. Review.

PMID:
22397946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk